BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DataCutoff//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DataCutoff · $TGTX readouts
X-WR-CALDESC:Clinical-trial primary completion dates from ClinicalTrials.go
 v\, refreshed nightly by DataCutoff. Not investment advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05877963-pcd@datacutoff.com
DTSTAMP:20261118T142521Z
DTSTART;VALUE=DATE:20270121
DTEND;VALUE=DATE:20270122
SUMMARY:ENHANCE readout (P3) · TG Therapeutics\, Inc. $TGTX
DESCRIPTION:Study to Evaluate Safety\, Efficacy and Pharmacokinetics (PK) o
 f a Modified Regimen of Ublituximab\n\nPrimary completion date: 2027-01-21
  (estimated)\nOriginally planned: 2025-06 (+19.7 months)\nPhase 3 · Neuro
  · Relapsing Multiple Sclerosis\nEnrollment: 800 · Sites: 51\n\nPrimary 
 completion = last participant's primary-endpoint data collected\; topline 
 results usually follow weeks to months later. Sponsor-reported\, often an 
 estimate. Not investment advice.\n\nhttps://datacutoff.com/radar.html?nct=
 NCT05877963\nhttps://clinicaltrials.gov/study/NCT05877963
URL:https://datacutoff.com/radar.html?nct=NCT05877963
CATEGORIES:Neuro,Phase 3
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07503873-pcd@datacutoff.com
DTSTAMP:20261118T142521Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Ublituximab readout (P2) · TG Therapeutics\, Inc. $TGTX
DESCRIPTION:A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcuta
 neous (SC) Ublituximab Administered at Various Injection Sites and Relativ
 e Bioavailability Via Autoinjector (AI) Ve…\n\nPrimary completion date: 
 2027-07-31 (estimated)\nPhase 2 · Neuro · Multiple Sclerosis\nEnrollment
 : 350 · Sites: 44\n\nPrimary completion = last participant's primary-endp
 oint data collected\; topline results usually follow weeks to months later
 . Sponsor-reported\, often an estimate. Not investment advice.\n\nhttps://
 datacutoff.com/radar.html?nct=NCT07503873\nhttps://clinicaltrials.gov/stud
 y/NCT07503873
URL:https://datacutoff.com/radar.html?nct=NCT07503873
CATEGORIES:Neuro,Phase 2
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
